quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·570d
PRRelease
Exscientia Plc logo
Rallybio Corporation logo

Data Demonstrating ENPP1 Inhibition as a Therapeutic Approach for Later-onset Hypophosphatasia Presented at the American Society for Bone and Mineral Research 2024 Annual Meeting

EXAI· Exscientia PlcRLYB· Rallybio Corporation
Health Care
Original source

Companies

  • EXAI
    Exscientia Plc
    Health Care
  • RLYB
    Rallybio Corporation
    Health Care

Recent analyst ratings

  • Apr 9RLYBUpdateH.C. Wainwright-
  • Jul 9EXAIUpdateTD Cowen-
  • May 15RLYBUpdateJP Morgan-
  • Feb 7RLYBUpdateJefferies$1.50
  • Jan 5EXAIUpdateBofA Securities$9.00
  • Apr 17RLYBUpdateH.C. Wainwright$18.00

Related

  • SEC10d
    Amendment: SEC Form SCHEDULE 13G/A filed by Rallybio Corporation
  • SEC23d
    Rallybio Corporation filed SEC Form 8-K: Leadership Update
  • SEC38d
    SEC Form 10-K filed by Rallybio Corporation
  • INSIDER44d
    New insider Fmr Llc claimed ownership of 211,798 shares (SEC Form 3)
  • SEC48d
    Amendment: SEC Form SCHEDULE 13G/A filed by Rallybio Corporation
  • SEC48d
    SEC Form SCHEDULE 13G filed by Rallybio Corporation
  • SEC52d
    SEC Form 425 filed by Rallybio Corporation
  • SEC52d
    Rallybio Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022